We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Clinical Updates

Intermittent Fasting for Weight Loss in Night Shift Workers: A Three-Arm Superiority Randomised Clinical Trial

MedXY Editorial Team•Oct 2, 2025•Clinical Updates
clinical trialinsulin resistanceintermittent fastingweight loss

Background

Night shift work is associated with weight gain and an increased risk of developing type 2 diabetes due to disrupted circadian rhythms and lifestyle factors. Intermittent fasting (IF) and continuous energy restriction (CER) are dietary approaches used to promote weight loss and improve metabolic health. However, their effectiveness specifically in night shift workers has been under-investigated.

This study aimed to evaluate the effectiveness of two modified IF protocols compared to CER on weight loss and insulin resistance among overweight or obese night shift workers.

Methods

A three-arm, parallel-group randomised superiority clinical trial was conducted in Melbourne and Adelaide, Australia. Eligible participants were night shift workers aged between 25 and 65 years with overweight or obesity. Participants were randomised in a 1:1:1 ratio to one of three groups: continuous energy restriction (CER), or one of two modified intermittent fasting strategies.

The two IF strategies involved consuming a reduced energy intake of 2100 kJ/day on two designated days per week (modified IF), with the rest of the week following their usual diet. One IF group fasted on days off or day shifts (IF:2D), while the other fasted during night shifts (IF:2N). The intervention lasted 24 weeks.

Primary outcomes were body weight and insulin resistance assessed by the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) at 24 weeks. Weight assessors and participants were aware of group allocation, while biochemical outcome assessors and the study statistician were blinded. Statistical analysis employed mixed-effects regression models to compare groups.

Findings

Between October 2019 and February 2022, 250 participants were randomised: 85 to CER, 83 to IF:2D, and 82 to IF:2N. The average age was 46.8 years with 53.2% women. A total of 170 participants (68%) completed the study.

No significant differences were found between either IF strategy and CER for body weight change (IF:2D vs CER mean difference [MD] = -0.2 kg, 95% CI -6.4 to 5.9; IF:2N vs CER MD = -0.6 kg, 95% CI -6.8 to 5.6) or insulin resistance (IF:2D vs CER MD = -0.1, 95% CI -1.0 to 0.8; IF:2N vs CER MD = -0.3, 95% CI -0.5 to 1.2).

However, participants in the IF:2D group showed significantly lower total cholesterol and LDL cholesterol compared to CER (MD = -23.2 mg/dL and MD = -19.3 mg/dL respectively).

Fig. 2

Completer analysis revealed favorable changes across all groups in body weight, insulin resistance, body composition, blood pressure, and cardiometabolic markers. Importantly, no serious adverse events related to the intervention were reported.

Interpretation

After 24 weeks, no significant differences in weight loss or insulin resistance were observed between the modified intermittent fasting groups and continuous energy restriction. Despite this, clinically meaningful improvements in weight and metabolic health were achieved for most night shift workers who completed the intervention.

These findings suggest that both modified intermittent fasting and continuous energy restriction can be effective dietary strategies for managing weight and metabolic risk factors in night shift workers.

Funding and Registration

This study was funded by the National Health and Medical Research Council (APP1159762) and registered with the Australian New Zealand Clinical Trials Registry (ACTRN-12619001035112).

Reference

Bonham MP, Leung GKW, Rogers M, et al. Intermittent fasting for weight loss in night shift workers: a three-arm, superiority randomised clinical trial. EBioMedicine. 2025 Jul;117:105803. doi:10.1016/j.ebiom.2025.105803 IF: 10.8 Q1 B1.

PDF (2.3 MB)

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Comparing Calorie-Restricted DASH, Carbohydrate-Restricted, and Low-Purine Diets for Weight Loss and Serum Urate Control in Men with HyperuricemiaA 12-week randomized trial compared the effects of calorie-restricted DASH, carbohydrate-restricted, and low-purine diets on weight loss and serum urate levels in men with overweight or obesity and hyperuricemia, highlighting adherence and Sep 16, 2026Evaluating Cusatuzumab Combined with Venetoclax ± Azacitidine in Unfit Newly Diagnosed AML: Insights from the Phase Ib ELEVATE TrialThe phase Ib ELEVATE study demonstrates that cusatuzumab combined with venetoclax and azacitidine offers a promising tolerable and effective frontline therapy for patients with newly diagnosed acute myeloid leukemia ineligible for intensiveSep 9, 2026Therapeutic Hypothermia at 35°C vs. Controlled Normothermia in ICU Heatstroke: Insights from a Pilot RCTA pilot randomized trial comparing targeted temperature management at 35°C versus normothermia in intubated heatstroke patients showed no survival or neurological benefit from hypothermia but increased gastrointestinal injury and arrhythmiaSep 3, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Evaluating Complication Rates in Post-Weight-Loss Body Contouring: Comparing Surgery, GLP-1 Pharmacotherapy, Combination, and Lifestyle Approaches
This study investigates postoperative complication rates following body-contouring surgery among patients with differing weight-loss methods, revealing that weight-loss modality does not affect complications, while BMI and diabetes at surge
Sep 3, 2026
Gabapentin for Cough in Idiopathic Pulmonary Fibrosis: Efficacy and Safety Insights from a Randomized Controlled TrialA randomized, double-blind, placebo-controlled trial demonstrates gabapentin’s significant efficacy and acceptable safety for treating cough in IPF, supporting its clinical use amid limited alternatives.Sep 1, 2026
Impact of Weight-Loss Methods on Post-Bariatric Body Contouring Surgery Outcomes: A Comparative AnalysisThis study evaluates complication rates following body contouring after weight loss via bariatric surgery, GLP-1 receptor agonists, combination therapy, and lifestyle changes, finding weight-loss modality does not affect postoperative complSep 1, 2026